Bio-Rad Laboratories, Inc. (BIO)
369.95
+6.45
(+1.77%)
USD |
NYSE |
Oct 23, 16:00
370.15
+0.20
(+0.05%)
After-Hours: 20:00
Bio-Rad Laboratories Market Cap : 9.892B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 9.892B |
| October 22, 2026 | 9.719B |
| October 21, 2026 | 9.639B |
| October 20, 2026 | 9.479B |
| October 19, 2026 | 9.434B |
| October 16, 2026 | 9.457B |
| October 15, 2026 | 9.755B |
| October 14, 2026 | 9.691B |
| October 13, 2026 | 9.725B |
| October 12, 2026 | 9.744B |
| October 09, 2026 | 9.790B |
| October 08, 2026 | 9.636B |
| October 07, 2026 | 9.837B |
| October 06, 2026 | 9.862B |
| October 05, 2026 | 10.16B |
| October 02, 2026 | 9.870B |
| October 01, 2026 | 9.507B |
| September 30, 2026 | 10.10B |
| September 29, 2026 | 10.15B |
| September 28, 2026 | 10.10B |
| September 25, 2026 | 10.19B |
| September 24, 2026 | 10.36B |
| September 23, 2026 | 10.13B |
| September 22, 2026 | 10.15B |
| September 21, 2026 | 10.09B |
| Date | Value |
|---|---|
| September 18, 2026 | 10.06B |
| September 17, 2026 | 10.22B |
| September 16, 2026 | 10.13B |
| September 15, 2026 | 10.11B |
| September 14, 2026 | 9.854B |
| September 11, 2026 | 9.875B |
| September 10, 2026 | 9.860B |
| September 09, 2026 | 10.08B |
| September 08, 2026 | 10.16B |
| September 04, 2026 | 10.32B |
| September 03, 2026 | 10.37B |
| September 02, 2026 | 10.39B |
| September 01, 2026 | 10.19B |
| August 31, 2026 | 10.32B |
| August 28, 2026 | 10.37B |
| August 27, 2026 | 10.43B |
| August 26, 2026 | 10.39B |
| August 25, 2026 | 10.44B |
| August 24, 2026 | 10.21B |
| August 21, 2026 | 10.16B |
| August 20, 2026 | 10.07B |
| August 19, 2026 | 9.740B |
| August 18, 2026 | 9.430B |
| August 17, 2026 | 9.498B |
| August 14, 2026 | 9.526B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 249.14B |
| Danaher Corp. | 162.13B |
| Agilent Technologies, Inc. | 48.80B |
| Illumina, Inc. | 40.68B |
| Revvity, Inc. | 17.72B |
Market Cap Related Metrics
| PE Ratio | 44.82 |
| PS Ratio | 3.847 |
| Price to Book Value | 1.379 |
| Price to Free Cash Flow | 28.21 |
| Price | 369.95 |
| Earnings Yield | 2.23% |
| Operating PE Ratio | 42.39 |
| Normalized PE Ratio | 57.67 |